Statins and oral biofilm: simvastatin as a promising drug to control periodontal dysbiosis.

Rafaela Durrer Parolina de CarvalhoJéssica de Andrade MorenoSindy Magri RoqueDaniel Cheuk Hong ChanWilly Bustillos TorrezRafael Nóbrega StippBruno Bueno-SilvaPatrícia Oliveira de LimaKarina Cogo-Müller

Published in: Oral diseases (2022)

Simvastatin showed antimicrobial and antibiofilm activity against oral bacteria and may contribute to the control of dysbiosis, and may be considered in clinical studies as an adjuvant in the treatment of periodontitis.

Keyphrases

staphylococcus aureus
pseudomonas aeruginosa
cardiovascular disease
early stage
candida albicans
biofilm formation
type diabetes
emergency department
escherichia coli
drug induced
cystic fibrosis
combination therapy
adverse drug
replacement therapy
electronic health record
smoking cessation